Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897363 · ClinicalTrials.gov registry record
Hypoglycemia in Prader-Willi Syndrome
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 2
- Enrollment target
NCT01897363 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 2 participants.
The verdict
NCT01897363 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This project will study whether infants with Prader-Willi Syndrome experience low blood sugars after short periods of fasting. This study will also evaluate metabolic markers in the blood to determine if infants with Prader-Willi Syndrome process energy differently than other children during fasting.
Interventions
- OTHER Infants with Prader-Willi Syndrome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01897363
The ClinicalTrials.gov registry entry for NCT01897363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infants with Prader-Willi Syndrome is the first listed.
NCT01897363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01897363 about?
NCT01897363 is a clinical study titled "Hypoglycemia in Prader-Willi Syndrome". This project will study whether infants with Prader-Willi Syndrome experience low blood sugars after short periods of fasting. This study will also evaluate metabolic markers in the blood to determine if infants with Prader-Willi Syndrome process energy differently than other children during fasting...
What is the current status of trial NCT01897363?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2013-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01897363?
The interventions under investigation include: Infants with Prader-Willi Syndrome (OTHER).
Who is sponsoring clinical trial NCT01897363?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.